Related references
Note: Only part of the references are listed.Relationship between respiration deficiency and azole resistance in clinical Candida glabrata
Yibing Peng et al.
FEMS YEAST RESEARCH (2012)
Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance
Sonia Silva et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria
Michael A. Pfaller et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida Time for harmonization of CLSI and EUCAST broth microdilution methods
M. A. Pfaller et al.
DRUG RESISTANCE UPDATES (2010)
Regulation of multidrug resistance in pathogenic fungi
Joachim Morschhaeuser
FUNGAL GENETICS AND BIOLOGY (2010)
Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole
Rajendra J. Kothavade et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Invasive Candidiasis: An Overview from Taiwan
Sheng-Yuan Ruan et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2009)
Genetic Basis of Antifungal Drug Resistance
Chelsea Marie et al.
CURRENT FUNGAL INFECTION REPORTS (2009)
A gain-of-function mutation in the transcription factor Upc2p causes Upregulation of ergosterol biosynthesis genes and increased Fluconazole resistance in a clinical Candida albicans isolate
Nico Dunkel et al.
EUKARYOTIC CELL (2008)
Prospective observational study of candidemia in Sao Paulo, Brazil: Incidence rate, epidemiology, and predictors of mortality
Arnaldo L. Colombo et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Mechanisms of azole resistance in a clinical isolate of Candida tropicalis
P Vandeputte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Promoter-dependent disruption of genes: simple, rapid, and specific PCR-based method with application to three different yeast
TD Edlind et al.
CURRENT GENETICS (2005)
Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance
M Sanguinetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Relationships between respiration and susceptibility to azole antifungals in Candida glabrata
S Brun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Candida tropicalis in a neonatal intensive care unit:: Epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen
E Roilides et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Characterization of the mitochondrial respiratory pathways in Candida albicans
EJ Helmerhorst et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2002)
Risk factors for Candida tropicalis fungemia in patients with cancer
DP Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2001)
Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors
KW Henry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750
F Barchiesi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole
KA Marr et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
